ESRD patients | healthy controls | P-value | ||
---|---|---|---|---|
number of individuals | 139 | 111 | ||
age (yrs)* | 46 (18-78) | 50 (21-78) | 0.13 | |
sexe (male) | 75% | 48% | < 0.01 | |
CMV seropositive | 53% | 59% | 0.10 | |
CMV IgG (AU/mL)* | 54 (6-252) | 47 (6-199) | 0.54 | |
underlying kidney disease | ||||
hypertensive nephropathy | 36.6% | |||
primary glomerulopathy | 20.1% | |||
diabetic nephropathy | 7.5% | |||
polycystic kidney disease | 0.0% | |||
other | 30.6% | |||
unknown | 5.2% | |||
type of renal replacement therapy | ||||
hemodialysis | 41% | |||
peritoneal dialysis | 24.6% | |||
previous kidney transplantation | 4.5% | |||
none | 29.9% |